Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Stearoyl-Chitosan Coated Nanoparticles Obtained by Microemulsion Cold Dilution Technique.

Chirio D, Peira E, Sapino S, Dianzani C, Barge A, Muntoni E, Morel S, Gallarate M.

Int J Mol Sci. 2018 Nov 30;19(12). pii: E3833. doi: 10.3390/ijms19123833.

2.

N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK.

Pippione AC, Sainas S, Federico A, Lupino E, Piccinini M, Kubbutat M, Contreras JM, Morice C, Barge A, Ducime A, Boschi D, Al-Karadaghi S, Lolli ML.

Medchemcomm. 2018 Apr 12;9(6):963-968. doi: 10.1039/c8md00068a. eCollection 2018 Jun 1.

3.

4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.

Pippione AC, Federico A, Ducime A, Sainas S, Boschi D, Barge A, Lupino E, Piccinini M, Kubbutat M, Contreras JM, Morice C, Al-Karadaghi S, Lolli ML.

Medchemcomm. 2017 Aug 25;8(9):1850-1855. doi: 10.1039/c7md00278e. eCollection 2017 Sep 1.

4.

A novel synthesis of N-hydroxy-3-aroylindoles and 3-aroylindoles.

Ieronimo G, Palmisano G, Maspero A, Marzorati A, Scapinello L, Masciocchi N, Cravotto G, Barge A, Simonetti M, Ameta KL, Nicholas KM, Penoni A.

Org Biomol Chem. 2018 Oct 3;16(38):6853-6859. doi: 10.1039/c8ob01471j.

PMID:
30065979
5.

Microwave Irradiation in Micro- Meso-Fluidic Systems; Hybrid Technology has Issued the Challenge.

Tagliapietra S, Calcio Gaudino E, Martina K, Barge A, Cravotto G.

Chem Rec. 2019 Jan;19(1):98-117. doi: 10.1002/tcr.201800057. Epub 2018 Jul 25. Review.

PMID:
30044531
6.

Lipophilic Prodrug of Floxuridine Loaded into Solid Lipid Nanoparticles: In Vitro Cytotoxicity Studies on Different Human Cancer Cell Lines.

Chirio D, Peira E, Battaglia L, Ferrara B, Barge A, Sapino S, Giordano S, Dianzani C, Gallarate M.

J Nanosci Nanotechnol. 2018 Jan 1;18(1):556-563. doi: 10.1166/jnn.2018.13964.

PMID:
29768881
7.

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.

Roohullah A, Cooper A, Lomax AJ, Aung J, Barge A, Chow L, McHale M, Desai J, Whittle JR, Tran B, de Souza P, Horvath LG.

Invest New Drugs. 2018 Oct;36(5):886-894. doi: 10.1007/s10637-018-0588-7. Epub 2018 May 16.

PMID:
29766337
8.

Wet air oxidation of cresylic spent caustic - A model compound study over graphene oxide (GO) and ruthenium/GO catalysts.

Barge AS, Vaidya PD.

J Environ Manage. 2018 Apr 15;212:479-489. doi: 10.1016/j.jenvman.2018.01.066. Epub 2018 Feb 22.

PMID:
29459340
9.

Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications.

Bosca F, Bielecki PA, Exner AA, Barge A.

Bioconjug Chem. 2018 Feb 21;29(2):234-240. doi: 10.1021/acs.bioconjchem.7b00732. Epub 2018 Jan 31.

PMID:
29365258
10.

EPR and photophysical characterization of six bioactive oxidovanadium(IV) complexes in the conditions of in vitro cell tests.

Lovisari M, Volpi G, Marabello D, Cadamuro S, Deagostino A, Diana E, Barge A, Gallicchio M, Boscaro V, Ghibaudi E.

J Inorg Biochem. 2017 May;170:55-62. doi: 10.1016/j.jinorgbio.2017.02.009. Epub 2017 Feb 13.

11.

Combined Microwaves/Ultrasound, a Hybrid Technology.

Martina K, Tagliapietra S, Barge A, Cravotto G.

Top Curr Chem (Cham). 2016 Dec;374(6):79. doi: 10.1007/s41061-016-0082-7. Epub 2016 Nov 10. Review.

PMID:
27832428
12.

4-Methylzymosterone and Other Intermediates of Sterol Biosynthesis from Yeast Mutants Engineered in the ERG27 Gene Encoding 3-Ketosteroid Reductase.

Ferrante T, Barge A, Taramino S, Oliaro-Bosso S, Balliano G.

Lipids. 2016 Sep;51(9):1103-13. doi: 10.1007/s11745-016-4173-6. Epub 2016 Jul 15.

PMID:
27421732
13.

Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies.

Peira E, Chirio D, Battaglia L, Barge A, Chegaev K, Gigliotti CL, Ferrara B, Dianzani C, Gallarate M.

J Microencapsul. 2016 Jun;33(4):381-90. doi: 10.1080/02652048.2016.1202342. Epub 2016 Jun 29.

14.

Microwave-Assisted Synthesis and Physicochemical Characterization of Tetrafuranylporphyrin-Grafted Reduced-Graphene Oxide.

Bosca F, Orio L, Tagliapietra S, Corazzari I, Turci F, Martina K, Pastero L, Cravotto G, Barge A.

Chemistry. 2016 Jan 26;22(5):1608-13. doi: 10.1002/chem.201503887. Epub 2016 Jan 7.

PMID:
26603672
15.

Interplay Between Mechanochemistry and Sonochemistry.

Cintas P, Cravotto G, Barge A, Martina K.

Top Curr Chem. 2015;369:239-84. doi: 10.1007/128_2014_623.

PMID:
25860254
16.

Optimizing the high-field relaxivity by self-assembling of macrocyclic Gd(III) complexes.

Lawson D, Barge A, Terreno E, Parker D, Aime S, Botta M.

Dalton Trans. 2015 Mar 21;44(11):4910-7. doi: 10.1039/c4dt02971b.

17.

A novel SWCNT platform bearing DOTA and β-cyclodextrin units. "One shot" multidecoration under microwave irradiation.

Calcio Gaudino E, Tagliapietra S, Martina K, Barge A, Lolli M, Terreno E, Lembo D, Cravotto G.

Org Biomol Chem. 2014 Jul 14;12(26):4708-15. doi: 10.1039/c4ob00611a.

PMID:
24872207
18.

Synthesis, characterization and cell viability test of six vanadyl complexes with acetylacetonate derivatives.

Sgarbossa S, Diana E, Marabello D, Deagostino A, Cadamuro S, Barge A, Laurenti E, Gallicchio M, Boscaro V, Ghibaudi E.

J Inorg Biochem. 2013 Nov;128:26-37. doi: 10.1016/j.jinorgbio.2013.07.015. Epub 2013 Jul 18.

PMID:
23911568
19.

Design and Synthesis of a γ(1)β(8)-Cyclodextrin Oligomer: A New Platform with Potential Application as a Dendrimeric Multicarrier.

Barge A, Caporaso M, Cravotto G, Martina K, Tosco P, Aime S, Carrera C, Gianolio E, Pariani G, Corpillo D.

Chemistry. 2013 Sep 2;19(36):12086-92. doi: 10.1002/chem.201301215. Epub 2013 Jul 22.

20.

Microwave-assisted extraction of edible Cicerbita alpina shoots and its LC-MS phenolic profile.

Alexandru L, Pizzale L, Conte L, Barge A, Cravotto G.

J Sci Food Agric. 2013 Aug 30;93(11):2676-82. doi: 10.1002/jsfa.6082. Epub 2013 Mar 22.

PMID:
23526184
21.

A carborane-derivative "click" reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent.

Toppino A, Bova ME, Geninatti Crich S, Alberti D, Diana E, Barge A, Aime S, Venturello P, Deagostino A.

Chemistry. 2013 Jan 7;19(2):721-8. doi: 10.1002/chem.201201634. Epub 2012 Nov 14.

PMID:
23154917
22.

UAE, MAE, SFE-CO2 and classical methods for the extraction of Mitragyna speciosa leaves.

Orio L, Alexandru L, Cravotto G, Mantegna S, Barge A.

Ultrason Sonochem. 2012 May;19(3):591-5. doi: 10.1016/j.ultsonch.2011.10.001. Epub 2011 Oct 8.

PMID:
22054912
23.

MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.

Geninatti-Crich S, Alberti D, Szabo I, Deagostino A, Toppino A, Barge A, Ballarini F, Bortolussi S, Bruschi P, Protti N, Stella S, Altieri S, Venturello P, Aime S.

Chemistry. 2011 Jul 18;17(30):8479-86. doi: 10.1002/chem.201003741. Epub 2011 Jun 10.

24.

The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.

Lattuada L, Barge A, Cravotto G, Giovenzana GB, Tei L.

Chem Soc Rev. 2011 May;40(5):3019-49. doi: 10.1039/c0cs00199f. Epub 2011 Mar 8. Review.

PMID:
21384039
25.

Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity.

Tei L, Mazooz G, Shellef Y, Avni R, Vandoorne K, Barge A, Kalchenko V, Dewhirst MW, Chaabane L, Miragoli L, Longo D, Neeman M, Aime S.

Contrast Media Mol Imaging. 2010 Jul-Aug;5(4):213-22. doi: 10.1002/cmmi.392.

PMID:
20812289
26.

Biocompatibility and calcification of bovine pericardium employed for the construction of cardiac bioprostheses treated with different chemical crosslink methods.

Jorge-Herrero E, Fonseca C, Barge AP, Turnay J, Olmo N, Fernández P, Lizarbe MA, García Páez JM.

Artif Organs. 2010 May;34(5):E168-76. doi: 10.1111/j.1525-1594.2009.00978.x.

PMID:
20633147
27.

Target visualization by MRI using the avidin/biotin amplification route: synthesis and testing of a biotin-Gd-DOTA monoamide trimer.

Tei L, Barge A, Geninatti Crich S, Pagliarin R, Negri V, Ramella D, Cravotto G, Aime S.

Chemistry. 2010 Jul 19;16(27):8080-7. doi: 10.1002/chem.201000508.

PMID:
20533461
28.

Microwave-assisted Maillard reactions for the preparation of advanced glycation end products (AGEs).

Visentin S, Medana C, Barge A, Giancotti V, Cravotto G.

Org Biomol Chem. 2010 May 21;8(10):2473-7. doi: 10.1039/c000789g. Epub 2010 Mar 25.

PMID:
20448908
29.

Synthesis of 1-octacosanol and GC-C-IRMS discrimination of samples from different origin.

Cravotto G, Calcio Gaudino E, Barge A, Binello A, Albertino A, Aghemo C.

Nat Prod Res. 2010 Mar;24(5):428-39. doi: 10.1080/14786410903194498.

PMID:
20306365
30.

Alkyne-azide click reaction catalyzed by metallic copper under ultrasound.

Cintas P, Barge A, Tagliapietra S, Boffa L, Cravotto G.

Nat Protoc. 2010 Mar;5(3):607-16. doi: 10.1038/nprot.2010.1. Epub 2010 Mar 4.

PMID:
20203675
31.

Synthesis, characterization and potential application of monoacyl-cyclodextrins.

Martina K, Puntambekar DS, Barge A, Gallarate M, Chirio D, Cravotto G.

Carbohydr Res. 2010 Jan 26;345(2):191-8. doi: 10.1016/j.carres.2009.11.009. Epub 2009 Nov 11.

PMID:
19948338
32.

Ultrasound-promoted copper-catalyzed azide-alkyne cycloaddition.

Cravotto G, Fokin VV, Garella D, Binello A, Boffa L, Barge A.

J Comb Chem. 2010 Jan-Feb;12(1):13-5. doi: 10.1021/cc900150d. No abstract available.

33.

Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.

Barge A, Cappelletti E, Cravotto G, Ferrigato A, Lattuada L, Marinoni F, Tei L.

Org Biomol Chem. 2009 Sep 21;7(18):3810-6. doi: 10.1039/b905369g. Epub 2009 Jul 20.

PMID:
19707687
34.

Towards improved boron neutron capture therapy agents: evaluation of in vitro cellular uptake of a glutamine-functionalized carborane.

Crivello A, Nervi C, Gobetto R, Crich SG, Szabo I, Barge A, Toppino A, Deagostino A, Venturello P, Aime S.

J Biol Inorg Chem. 2009 Aug;14(6):883-90. doi: 10.1007/s00775-009-0500-1. Epub 2009 Apr 10.

PMID:
19360442
36.

New cyclodextrin dimers and trimers capable of forming supramolecular adducts with shape-specific ligands.

Aime S, Gianolio E, Arena F, Barge A, Martina K, Heropoulos G, Cravotto G.

Org Biomol Chem. 2009 Jan 21;7(2):370-9. doi: 10.1039/b812172a. Epub 2008 Nov 20.

37.

Tuning glutamine binding modes in Gd-DOTA-based probes for an improved MRI visualization of tumor cells.

Stefania R, Tei L, Barge A, Geninatti Crich S, Szabo I, Cabella C, Cravotto G, Aime S.

Chemistry. 2009;15(1):76-85. doi: 10.1002/chem.200801567.

PMID:
19058266
38.

Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: a new dual agent for innovative MRI/BNCT applications.

Aime S, Barge A, Crivello A, Deagostino A, Gobetto R, Nervi C, Prandi C, Toppino A, Venturello P.

Org Biomol Chem. 2008 Dec 7;6(23):4460-6. doi: 10.1039/b808804g. Epub 2008 Oct 24.

PMID:
19005608
39.

1H and 17O NMR relaxometric study in aqueous solution of Gd(III) complexes of EGTA-like derivatives bearing methylenephosphonic groups.

Tei L, Botta M, Lovazzano C, Barge A, Milone L, Aime S.

Magn Reson Chem. 2008;46 Suppl 1:S86-93. doi: 10.1002/mrc.2316.

PMID:
18855344
40.

Improved adhesion to mucosal cells of water-soluble chitosan tetraalkylammonium salts.

Cardile V, Frasca G, Rizza L, Bonina F, Puglia C, Barge A, Chiambretti N, Cravotto G.

Int J Pharm. 2008 Oct 1;362(1-2):88-92. doi: 10.1016/j.ijpharm.2008.06.017. Epub 2008 Jun 26.

PMID:
18634863
41.

The York Region Methamphetamine Strategy.

Cronkwright Kirkos W, Carrique T, Griffen K, La Barge AP.

CMAJ. 2008 Jun 17;178(13):1655-6. doi: 10.1503/cmaj.071299. Review. No abstract available.

42.

Bifunctional ligands based on the DOTA-monoamide cage.

Barge A, Tei L, Upadhyaya D, Fedeli F, Beltrami L, Stefanìa R, Aime S, Cravotto G.

Org Biomol Chem. 2008 Apr 7;6(7):1176-84. doi: 10.1039/b715844k. Epub 2008 Feb 22.

PMID:
18362955
43.

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors.

LoRusso PM, Gadgeel SM, Wozniak A, Barge AJ, Jones HK, DelProposto ZS, DeLuca PA, Evelhoch JL, Boerner SA, Wheeler C.

Invest New Drugs. 2008 Apr;26(2):159-67. doi: 10.1007/s10637-008-9112-9. Epub 2008 Jan 25.

PMID:
18219445
44.

Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.

Terreno E, Barge A, Beltrami L, Cravotto G, Castelli DD, Fedeli F, Jebasingh B, Aime S.

Chem Commun (Camb). 2008 Feb 7;(5):600-2. doi: 10.1039/b715383j. Epub 2007 Nov 26.

PMID:
18209802
45.

Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.

Conrad C, Ischenko I, Köhl G, Wiegand U, Guba M, Yezhelyev M, Ryan AJ, Barge A, Geissler EK, Wedge SR, Jauch KW, Bruns CJ.

Anticancer Drugs. 2007 Jun;18(5):569-79.

PMID:
17414626
46.

How to determine free Gd and free ligand in solution of Gd chelates. A technical note.

Barge A, Cravotto G, Gianolio E, Fedeli F.

Contrast Media Mol Imaging. 2006 Sep-Oct;1(5):184-8.

PMID:
17193695
47.

Cellular labeling with Gd(III) chelates: only high thermodynamic stabilities prevent the cells acting as 'sponges' of Gd3+ ions.

Cabella C, Crich SG, Corpillo D, Barge A, Ghirelli C, Bruno E, Lorusso V, Uggeri F, Aime S.

Contrast Media Mol Imaging. 2006 Jan-Feb;1(1):23-9.

PMID:
17193597
48.

Inhibitory effect of umbelliferone aminoalkyl derivatives on oxidosqualene cyclases from S. cerevisiae, T. cruzi, P. carinii, H. sapiens, and A. thaliana: a structure-activity study.

Oliaro-Bosso S, Viola F, Taramino S, Tagliapietra S, Barge A, Cravotto G, Balliano G.

ChemMedChem. 2007 Feb;2(2):226-33.

PMID:
17154325
49.

In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes.

Geninatti Crich S, Cabella C, Barge A, Belfiore S, Ghirelli C, Lattuada L, Lanzardo S, Mortillaro A, Tei L, Visigalli M, Forni G, Aime S.

J Med Chem. 2006 Aug 10;49(16):4926-36.

PMID:
16884304
50.

Improving the design of phase II trials of cytostatic anticancer agents.

Stone A, Wheeler C, Barge A.

Contemp Clin Trials. 2007 Feb;28(2):138-45. Epub 2006 Jul 14. Review.

PMID:
16843736

Supplemental Content

Support Center